ABBOTT LABORATORIES (ABL.DE) Stock Fundamental Analysis
FRA:ABL - Deutsche Boerse Ag - US0028241000 - Common Stock - Currency: EUR
Taking everything into account, ABL scores 7 out of 10 in our fundamental rating. ABL was compared to 59 industry peers in the Health Care Equipment & Supplies industry. ABL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ABL has a correct valuation and a medium growth rate. With these ratings, ABL could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
ABL had positive earnings in the past year.
In the past year ABL had a positive cash flow from operations.
In the past 5 years ABL has always been profitable.
In the past 5 years ABL always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 16.58%, ABL belongs to the best of the industry, outperforming 93.22% of the companies in the same industry.
ABL has a better Return On Equity (27.66%) than 96.61% of its industry peers.
With a decent Return On Invested Capital value of 9.23%, ABL is doing good in the industry, outperforming 77.97% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ABL is above the industry average of 8.10%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.58% | ||
| ROE | 27.66% | ||
| ROIC | 9.23% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
1.3 Margins
The Profit Margin of ABL (31.89%) is better than 98.31% of its industry peers.
In the last couple of years the Profit Margin of ABL has grown nicely.
The Operating Margin of ABL (17.38%) is better than 79.66% of its industry peers.
ABL's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 56.06%, ABL is in line with its industry, outperforming 54.24% of the companies in the same industry.
In the last couple of years the Gross Margin of ABL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.38% | ||
| PM (TTM) | 31.89% | ||
| GM | 56.06% |
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ABL is creating some value.
ABL has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ABL has been reduced compared to 5 years ago.
The debt/assets ratio for ABL has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 6.00 indicates that ABL is not in any danger for bankruptcy at the moment.
ABL's Altman-Z score of 6.00 is amongst the best of the industry. ABL outperforms 89.83% of its industry peers.
The Debt to FCF ratio of ABL is 1.99, which is an excellent value as it means it would take ABL, only 1.99 years of fcf income to pay off all of its debts.
ABL's Debt to FCF ratio of 1.99 is amongst the best of the industry. ABL outperforms 84.75% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that ABL is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.26, ABL is in line with its industry, outperforming 57.63% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.99 | ||
| Altman-Z | 6 |
ROIC/WACC1.09
WACC8.5%
2.3 Liquidity
ABL has a Current Ratio of 1.78. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
ABL has a Current ratio (1.78) which is comparable to the rest of the industry.
A Quick Ratio of 1.27 indicates that ABL should not have too much problems paying its short term obligations.
The Quick ratio of ABL (1.27) is comparable to the rest of the industry.
The current and quick ratio evaluation for ABL is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.78 | ||
| Quick Ratio | 1.27 |
3. Growth
3.1 Past
ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.11%, which is quite good.
The Earnings Per Share has been growing slightly by 7.59% on average over the past years.
The Revenue has been growing slightly by 5.85% in the past year.
The Revenue has been growing slightly by 5.63% on average over the past years.
EPS 1Y (TTM)10.11%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%10.53%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%7.37%
3.2 Future
Based on estimates for the next years, ABL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.82% on average per year.
ABL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.19% yearly.
EPS Next Y11.61%
EPS Next 2Y10.91%
EPS Next 3Y10.72%
EPS Next 5Y9.82%
Revenue Next Year6.48%
Revenue Next 2Y7.16%
Revenue Next 3Y7.22%
Revenue Next 5Y7.19%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 26.99, the valuation of ABL can be described as expensive.
ABL's Price/Earnings ratio is a bit cheaper when compared to the industry. ABL is cheaper than 71.19% of the companies in the same industry.
ABL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 23.03 indicates a rather expensive valuation of ABL.
ABL's Price/Forward Earnings ratio is in line with the industry average.
ABL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 35.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.99 | ||
| Fwd PE | 23.03 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as ABL.
ABL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ABL is cheaper than 62.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.58 | ||
| EV/EBITDA | 22.33 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ABL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.32
PEG (5Y)3.56
EPS Next 2Y10.91%
EPS Next 3Y10.72%
5. Dividend
5.1 Amount
ABL has a Yearly Dividend Yield of 1.87%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.08, ABL pays a bit more dividend than its industry peers.
Compared to the average S&P500 Dividend Yield of 2.40, ABL is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.87% |
5.2 History
The dividend of ABL is nicely growing with an annual growth rate of 11.40%!
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
ABL pays out 28.92% of its income as dividend. This is a sustainable payout ratio.
ABL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.92%
EPS Next 2Y10.91%
EPS Next 3Y10.72%
FRA:ABL (8/8/2025, 9:54:06 AM)
113.64
+0.56 (+0.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners80.44%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap197.72B
Analysts78.18
Price Target125.38 (10.33%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.87% |
Yearly Dividend1.94
Dividend Growth(5Y)11.4%
DP28.92%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.21%
Min EPS beat(2)-1.16%
Max EPS beat(2)0.73%
EPS beat(4)2
Avg EPS beat(4)0.36%
Min EPS beat(4)-1.16%
Max EPS beat(4)2.22%
EPS beat(8)5
Avg EPS beat(8)0.86%
EPS beat(12)9
Avg EPS beat(12)5.62%
EPS beat(16)13
Avg EPS beat(16)9.57%
Revenue beat(2)0
Avg Revenue beat(2)-1.35%
Min Revenue beat(2)-1.37%
Max Revenue beat(2)-1.33%
Revenue beat(4)0
Avg Revenue beat(4)-0.95%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.19%
Revenue beat(8)2
Avg Revenue beat(8)-0.01%
Revenue beat(12)6
Avg Revenue beat(12)1.49%
Revenue beat(16)10
Avg Revenue beat(16)3.05%
PT rev (1m)-0.62%
PT rev (3m)0.13%
EPS NQ rev (1m)0.08%
EPS NQ rev (3m)0.26%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)0.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.12%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.99 | ||
| Fwd PE | 23.03 | ||
| P/S | 5.44 | ||
| P/FCF | 34.58 | ||
| P/OCF | 25.72 | ||
| P/B | 4.72 | ||
| P/tB | 12 | ||
| EV/EBITDA | 22.33 |
EPS(TTM)4.21
EY3.7%
EPS(NY)4.93
Fwd EY4.34%
FCF(TTM)3.29
FCFY2.89%
OCF(TTM)4.42
OCFY3.89%
SpS20.9
BVpS24.1
TBVpS9.47
PEG (NY)2.32
PEG (5Y)3.56
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.58% | ||
| ROE | 27.66% | ||
| ROCE | 10.75% | ||
| ROIC | 9.23% | ||
| ROICexc | 10.26% | ||
| ROICexgc | 19.76% | ||
| OM | 17.38% | ||
| PM (TTM) | 31.89% | ||
| GM | 56.06% | ||
| FCFM | 15.72% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ROICexc(3y)12.18%
ROICexc(5y)11.89%
ROICexgc(3y)32.65%
ROICexgc(5y)35.03%
ROCE(3y)12.16%
ROCE(5y)11.86%
ROICexcg growth 3Y-24.08%
ROICexcg growth 5Y-8.19%
ROICexc growth 3Y-10.71%
ROICexc growth 5Y6.04%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.99 | ||
| Debt/EBITDA | 1.21 | ||
| Cap/Depr | 72.36% | ||
| Cap/Sales | 5.42% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 85% | ||
| Profit Quality | 49.3% | ||
| Current Ratio | 1.78 | ||
| Quick Ratio | 1.27 | ||
| Altman-Z | 6 |
F-Score7
WACC8.5%
ROIC/WACC1.09
Cap/Depr(3y)63.63%
Cap/Depr(5y)61.92%
Cap/Sales(3y)4.94%
Cap/Sales(5y)5.1%
Profit Quality(3y)82.78%
Profit Quality(5y)99.6%
High Growth Momentum
Growth
EPS 1Y (TTM)10.11%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%10.53%
EPS Next Y11.61%
EPS Next 2Y10.91%
EPS Next 3Y10.72%
EPS Next 5Y9.82%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%7.37%
Revenue Next Year6.48%
Revenue Next 2Y7.16%
Revenue Next 3Y7.22%
Revenue Next 5Y7.19%
EBIT growth 1Y11.53%
EBIT growth 3Y-6.62%
EBIT growth 5Y8.41%
EBIT Next Year29.19%
EBIT Next 3Y15.9%
EBIT Next 5Y10.98%
FCF growth 1Y-2.43%
FCF growth 3Y-9.78%
FCF growth 5Y7.14%
OCF growth 1Y3.36%
OCF growth 3Y-6.69%
OCF growth 5Y6.88%